Integrated Diagnostics (IDGXF) Stock Price, News & Analysis

Company Overview

Integrated Diagnostics Holdings PSC (OTCMKTS: IDGXF) is a leading provider of diagnostic services in the United Arab Emirates and the broader Gulf Cooperation Council (GCC) region. Headquartered in Abu Dhabi, the company operates an extensive network of pathology laboratories and radiology facilities, offering a comprehensive suite of clinical testing and medical imaging services. Its offerings span routine laboratory tests, advanced molecular diagnostics, histopathology, and a range of radiological modalities such as MRI, CT, ultrasound, and X-ray.

Since its founding in 1993, Integrated Diagnostics has expanded its footprint across the UAE, with patient service centers and lab collection points in Abu Dhabi, Dubai, and the Northern Emirates. The company also maintains strategic partnerships and referral arrangements with public and private hospitals, clinics, and specialty centers throughout the GCC. In addition to its core diagnostic business, Integrated Diagnostics invests in digital pathology and telemedicine solutions to support remote consultations and second-opinion services for complex cases.

Under the leadership of Group CEO Dr. Chirag Patel, Integrated Diagnostics has pursued a strategy of organic growth and selective acquisitions to broaden its service offerings and geographic reach. The company’s management team includes experienced professionals in laboratory science, healthcare operations, and quality assurance, ensuring adherence to international accreditation standards. By focusing on patient-centric care and technological innovation, Integrated Diagnostics aims to strengthen its position as a trusted partner for clinicians and healthcare providers across the Middle East.

Key Stats

• Today's Range: $0.54 to $0.54
• 50-Day Range: $0.32 to $0.54
• 52-Week Range: $0.48 to $0.54
• Volume: 10,000 shs
• Average Volume: 5,050 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IDGXF Stock Analysis - Frequently Asked Questions

How have IDGXF shares performed this year?

Integrated Diagnostics' stock was trading at $0.4191 on January 1st, 2025. Since then, IDGXF stock has increased by 28.9% and is now trading at $0.54.

How do I buy shares of Integrated Diagnostics?

Shares of IDGXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:IDGXF
• CIK: N/A
• Web: www.idhcorp.com
• Phone: 44-15-3484-7000
• Fax: N/A
• Employees: 6,692
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A